24 February 2020 - Prescription drug-price transparency alone is not enough to stem skyrocketing costs, but it is considered an important first step for states to take.
Transparency has helped move the drug-pricing issue forward at the state level with “remarkable momentum” as illustrated by 37 states passing a total of 60 separate drug-pricing laws in 2019, said Jennifer Reck, the project director for the National Academy for State Health Policy’s Center for State Rx Drug Pricing.
She was one of three panelists who took part in an expert discussion on prescription-drug pricing at the AMA State Advocacy Summit in Bonita Springs, Florida.